Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Innate Pharma S.A. Sponsored ADR (IPHA)

Inovio Pharmaceuticals, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR is the larger, with a market value of $160.9M against $125.6M — 1.3× the size. Innate Pharma S.A. Sponsored ADR grew revenue faster over the last twelve months: −4.17% against −54.8%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Innate Pharma S.A. Sponsored ADR leads on 9 and Inovio Pharmaceuticals, Inc. on 4.

Valuation

Metric INO IPHA Biotechnology median
P/E n/m n/m 10.60
P/S 258.10 n/m 9.40
P/B 22.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 206.11 0.12 9.02
Earnings yield (94.67%) (81.01%) (32.88%)
Free cash flow yield (80.41%) 0.00% (23.13%)

Profitability

Metric INO IPHA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) 0.00% (51.96%)
Return on assets (114.64%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO IPHA Biotechnology median
Revenue growth (TTM) (54.82%) (4.17%) 6.76%
EPS growth (last fiscal year) 54.18% 6.06% 29.88%
Revenue growth, 5-year CAGR (61.18%) (33.86%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO IPHA Biotechnology median
Debt to equity 0.00 (0.50) 0.00
Current ratio 1.00 0.60 4.97
Net debt to EBITDA 0.70 0.22 1.01

Dividend

Metric INO IPHA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO IPHA Biotechnology median
Market cap 125.63m 160.85m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack